Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2012, Article ID 948653, 16 pages
http://dx.doi.org/10.6064/2012/948653
Review Article

Quantitative Cardiac Positron Emission Tomography: The Time Is Coming!

Department of Clinical Physiopathology, Nuclear Medicine Unit, University of Florence, Largo Brambilla 3, 50134 Florence, Italy

Received 5 July 2012; Accepted 14 August 2012

Academic Editors: J. Alpert, C. N. Aroney, R. Fulton, and J. van den Hoff

Copyright © 2012 Roberto Sciagrà. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Tillisch, R. Brunken, R. Marshall et al., “Reversibility of cardial wall-motion abnormalities predicted by positron tomography,” New England Journal of Medicine, vol. 314, no. 14, pp. 884–888, 1986. View at Google Scholar · View at Scopus
  2. K. L. Gould, R. A. Goldstein, N. A. Mullani et al., “Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82,” Journal of the American College of Cardiology, vol. 7, no. 4, pp. 775–789, 1986. View at Google Scholar · View at Scopus
  3. R. E. Stewart, M. Schwaiger, E. Molina et al., “Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease,” American Journal of Cardiology, vol. 67, no. 16, pp. 1303–1310, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Tamaki, Y. Yonekura, M. Senda et al., “Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography,” Journal of Nuclear Medicine, vol. 29, no. 7, pp. 1181–1188, 1988. View at Google Scholar · View at Scopus
  5. M. N. Walsh, S. R. Bergmann, R. L. Steele et al., “Delineation of impaired regional myocardial perfusion by positron emission tomography with H215O,” Circulation, vol. 78, no. 3, pp. 612–620, 1988. View at Google Scholar · View at Scopus
  6. L. L. Demer, K. L. Gould, R. A. Goldstein et al., “Assessment of coronary artery disease severity by positron emmison tomography. Comparison with quantitative arteriography in 193 patients,” Circulation, vol. 79, no. 4, pp. 825–835, 1989. View at Google Scholar · View at Scopus
  7. R. Brunken, M. Schwaiger, and M. Grover-McKay, “Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects,” Journal of the American College of Cardiology, vol. 10, no. 3, pp. 557–567, 1987. View at Google Scholar · View at Scopus
  8. P. E. P. Smanio, D. D. Watson, D. L. Segalla, E. L. Vinson, W. H. Smith, and G. A. Beller, “Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging,” Journal of the American College of Cardiology, vol. 30, no. 7, pp. 1687–1692, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sciagrà, “The expanding role of left ventricular functional assessment using gated myocardial perfusion SPECT: the supporting actor is stealing the scene,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 7, pp. 1107–1122, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. Bateman, “Advantages and disadvantages of PET and SPECT in a busy clinical practice,” Journal of Nuclear Cardiology, vol. 19, pp. S3–S11, 2012. View at Publisher · View at Google Scholar
  11. G. V. Heller, “Practical issues regarding the incorporation of PET into a busy SPECT practice,” Journal of Nuclear Cardiology, vol. 19, pp. S12–S18, 2012. View at Publisher · View at Google Scholar
  12. E. V. Garcia, “Physical attributes, limitations, and future potential for PET and SPECT,” Journal of Nuclear Cardiology, vol. 19, pp. S19–S29, 2012. View at Google Scholar
  13. M. M. Ter-Pogossian, “Instrumentation for cardiac positron emission tomography: background and historical perspective,” in Positron Emission Tomography of the Heart, S. R. Bergmann and B. E. Sobel, Eds., pp. 1–12, Futura Publishing, Mount Kisco, NY, USA, 1992. View at Google Scholar
  14. T. Beyer, D. W. Townsend, T. Brun et al., “A combined PET/CT scanner for clinical oncology,” Journal of Nuclear Medicine, vol. 41, no. 8, pp. 1369–1379, 2000. View at Google Scholar · View at Scopus
  15. S. DeBenedetti, C. E. Cowan, W. R. Konneker, and H. Primakoff, “On the angular distribution of two-photon annihilation radiation,” Physical Review, vol. 77, no. 2, pp. 205–212, 1950. View at Publisher · View at Google Scholar · View at Scopus
  16. M. E. Phelps, E. J. Hoffman, S. C. Huang, and M. M. Ter Pogossian, “Effect of positron range on spatial resolution,” Journal of Nuclear Medicine, vol. 16, no. 7, pp. 649–652, 1975. View at Google Scholar · View at Scopus
  17. M. Bergstrom, L. Eriksson, and C. Bohm, “Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections,” Journal of Computer Assisted Tomography, vol. 7, no. 1, pp. 42–50, 1983. View at Google Scholar · View at Scopus
  18. E. J. Hoffman, S. C. Huang, M. E. Phelps, and D. E. Kuhl, “Quantitation in positron emission computed tomography: 4. Effect of accidental coincidences,” Journal of Computer Assisted Tomography, vol. 5, no. 3, pp. 391–400, 1981. View at Google Scholar · View at Scopus
  19. J. M. Ollinger, “Detector efficiency and Compton scatter in fully 3D PET,” IEEE Transactions on Nuclear Science, vol. 42, no. 4, pp. 1168–1173, 1995. View at Google Scholar · View at Scopus
  20. M. E. Daube-Witherspoon, J. S. Karp, M. E. Casey et al., “PET performance measurements using the NEMA NU 2-2001 standard,” Journal of Nuclear Medicine, vol. 43, no. 10, pp. 1398–1409, 2002. View at Google Scholar · View at Scopus
  21. R. Lautamäki, T. L. Y. Brown, J. Merrill, and F. M. Bengel, “CT-based attenuation correction in 82Rb-myocardial perfusion PET-CT: incidence of misalignment and effect on regional tracer distribution,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 2, pp. 305–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, A. Guha, and S. Sdringola, “Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: a definitive analysis of causes, consequences, and corrections,” Journal of Nuclear Medicine, vol. 48, no. 7, pp. 1112–1121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Martinez-Möller, M. Souvatzoglou, N. Navab, M. Schwaiger, and S. G. Nekolla, “Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions,” Journal of Nuclear Medicine, vol. 48, no. 2, pp. 188–193, 2007. View at Google Scholar · View at Scopus
  24. A. Martinez-Möller, D. Zikic, R. M. Botnar et al., “Dual cardiac-respiratory gated PET: implementation and results from a feasibility study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 9, pp. 1447–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Le Guludec, R. Lautamäki, J. Knuuti, J. J. Bax, and F. M. Bengel, “Present and future of clinical cardiovascular PET imaging in Europe—a position statement by the European Council of Nuclear Cardiology (ECNC),” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 9, pp. 1709–1724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Schepis, O. Gaemperli, V. Treyer et al., “Absolute quantification of myocardial blood flow with 13N- ammonia and 3-dimensional PET,” Journal of Nuclear Medicine, vol. 48, no. 11, pp. 1783–1789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Conti, “State of the art and challenges of time-of-flight PET,” Physica Medica, vol. 25, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. G. P. Chen, K. R. Branch, A. M. Alessio et al., “Effect of reconstruction algorithms on myocardial blood flow measurement with 13N-ammonia PET,” Journal of Nuclear Medicine, vol. 48, no. 8, pp. 1259–1265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. D. Hove, R. Rasmussen, J. Freiberg, S. Holm, H. Kelbæk, and K. E. Kofoed, “Clinical evaluation of iterative reconstruction (ordered-subset expectation maximization) in dynamic positron emission tomography: quantitative effects on kinetic modeling with N-13 ammonia in healthy subjects,” Journal of Nuclear Cardiology, vol. 15, no. 4, pp. 530–534, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. Gropler, B. A. Siegel, and E. M. Geltman, “Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow,” Journal of Nuclear Medicine, vol. 32, no. 2, pp. 245–251, 1991. View at Google Scholar · View at Scopus
  31. J. Van Den Hoff, W. Burchert, H. G. Wolpers, G. J. Meyer, and H. Hundeshagen, “A kinetic model for cardiac PET with [1-carbon-11]-acetate,” Journal of Nuclear Medicine, vol. 37, no. 3, pp. 521–529, 1996. View at Google Scholar · View at Scopus
  32. J. Van den Hoff, W. Burchert, A. R. Börner et al., “[1-11C]acetate as a quantitative perfusion tracer in myocardial PET,” Journal of Nuclear Medicine, vol. 42, no. 8, pp. 1174–1182, 2001. View at Google Scholar · View at Scopus
  33. S. A. J. Timmer, M. Lubberink, T. Germans et al., “Potential of [11C]acetate for measuring myocardial blood flow: studies in normal subjects and patients with hypertrophic cardiomyopathy,” Journal of Nuclear Cardiology, vol. 17, no. 2, pp. 264–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Hur, J. H. Park, I. J. Kim et al., “Design and evaluation of a carbon-11 gas target having auxiliary cooling fins in the target cavity for the stable production of carbon-11,” Nuclear Instruments and Methods in Physics Research, Section A, vol. 655, pp. 108–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Maddahi, “Properties of an ideal PET perfusion tracer: new PET tracer cases and data,” Journal of Nuclear Cardiology, vol. 19, pp. S30–S37, 2012. View at Publisher · View at Google Scholar
  36. O. Ratib, M. E. Phelps, and S. C. Huang, “Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism,” Journal of Nuclear Medicine, vol. 23, no. 7, pp. 577–586, 1982. View at Google Scholar · View at Scopus
  37. T. Kudo, “Metabolic imaging using PET,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, supplement 1, pp. S49–S61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Melon and M. Schwaiger, “Imaging of metabolism and autonomic innervation of the heart by positron emission tomography,” European Journal of Nuclear Medicine, vol. 19, no. 6, pp. 453–464, 1992. View at Google Scholar · View at Scopus
  39. S. R. Bergmann, K. A. A. Fox, and A. L. Rand, “Quantification of regional myocardial blood flow in vivo with H215O,” Circulation, vol. 70, no. 4, pp. 724–733, 1984. View at Google Scholar · View at Scopus
  40. H. Iida, I. Kanno, A. Takahashi et al., “Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect,” Circulation, vol. 78, no. 1, pp. 104–115, 1988. View at Google Scholar · View at Scopus
  41. S. R. Bergmann, P. Herrero, J. Markham, C. J. Weinheimer, and M. N. Walsh, “Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography,” Journal of the American College of Cardiology, vol. 14, no. 3, pp. 639–652, 1989. View at Google Scholar · View at Scopus
  42. F. Hermansen, S. D. Rosen, F. Fath-Ordoubadi et al., “Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols,” European Journal of Nuclear Medicine, vol. 25, no. 7, pp. 751–759, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. P. A. Kaufmann and P. G. Camici, “Myocardial blood flow measurement by PET: technical aspects and clinical applications,” Journal of Nuclear Medicine, vol. 46, pp. 75–88, 2005. View at Google Scholar
  44. J. Machac, “Cardiac positron emission tomography imaging,” Seminars in Nuclear Medicine, vol. 35, no. 1, pp. 17–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. C. R. Bellina, O. Parodi, P. Camici et al., “Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow,” Journal of Nuclear Medicine, vol. 31, no. 8, pp. 1335–1343, 1990. View at Google Scholar · View at Scopus
  46. G. D. Hutchins, M. Schwaiger, K. C. Rosenspire, J. Krivokapich, H. Schelbert, and D. E. Kuhl, “Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging,” Journal of the American College of Cardiology, vol. 15, no. 5, pp. 1032–1042, 1990. View at Google Scholar · View at Scopus
  47. J. Krivokapich, G. T. Smith, S. C. Huang et al., “13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography,” Circulation, vol. 80, no. 5, pp. 1328–1337, 1989. View at Google Scholar · View at Scopus
  48. O. Muzik, R. S. B. Beanlands, G. D. Hutchins, T. J. Mangner, N. Nguyen, and M. Schwaiger, “Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET,” Journal of Nuclear Medicine, vol. 34, no. 1, pp. 83–91, 1993. View at Google Scholar · View at Scopus
  49. Y. Choi, S. C. Huang, R. A. Hawkins et al., “A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET,” Journal of Nuclear Medicine, vol. 34, no. 3, pp. 488–497, 1993. View at Google Scholar · View at Scopus
  50. T. R. DeGrado, M. W. Hanson, T. G. Turkington et al., “Estimation of myocardial blood flow for longitudinal studies with13N-labeled ammonia and positron emission tomography,” Journal of Nuclear Cardiology, vol. 3, no. 6, pp. 494–507, 1996. View at Google Scholar · View at Scopus
  51. P. Herrero, J. Markham, M. E. Shelton, C. J. Weinheimer, and S. R. Bergmann, “Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model,” Circulation, vol. 82, no. 4, pp. 1377–1386, 1990. View at Google Scholar · View at Scopus
  52. E. U. Nitzsche, Y. Choi, J. Czernin, C. K. Hoh, S. C. Huang, and H. R. Schelbert, “Noninvasive quantification of myocardial blood flow in humans: a direct comparison of the [13N] ammonia and the [15O]water techniques,” Circulation, vol. 93, no. 11, pp. 2000–2006, 1996. View at Google Scholar · View at Scopus
  53. L. Husmann, M. Wiegand, I. Valenta et al., “Diagnostic accuracy of myocardial perfusion imaging with single photon emission computed tomography and positron emission tomography: a comparison with coronary angiography,” International Journal of Cardiovascular Imaging, vol. 24, no. 5, pp. 511–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Herrero, J. Markham, M. E. Shelton, and S. R. Bergmann, “Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography,” Circulation Research, vol. 70, no. 3, pp. 496–507, 1992. View at Google Scholar · View at Scopus
  55. K. Yoshida, N. Mullani, and K. L. Gould, “Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia,” Journal of Nuclear Medicine, vol. 37, no. 10, pp. 1701–1712, 1996. View at Google Scholar · View at Scopus
  56. J. W. Lin, R. R. Sciacca, R. L. Chou, A. F. Laine, and S. R. Bergmann, “Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction,” Journal of Nuclear Medicine, vol. 42, no. 2, pp. 201–208, 2001. View at Google Scholar · View at Scopus
  57. G. El Fakhri, A. Sitek, B. Guérin, M. F. Kijewski, M. F. Di Carli, and S. C. Moore, “Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses,” Journal of Nuclear Medicine, vol. 46, no. 8, pp. 1264–1271, 2005. View at Google Scholar · View at Scopus
  58. M. Lortie, R. S. B. Beanlands, K. Yoshinaga, R. Klein, J. N. DaSilva, and R. A. DeKemp, “Quantification of myocardial blood flow with 82Rb dynamic PET imaging,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 11, pp. 1765–1774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Klein, R. S. B. Beanlands, and R. A. DeKemp, “Quantification of myocardial blood flow and flow reserve: technical aspects,” Journal of Nuclear Cardiology, vol. 17, no. 4, pp. 555–570, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. A. M. Groves, M. E. Speechly-Dick, J. C. Dickson et al., “Cardiac 82rubidium PET/CT: initial European experience,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no. 12, pp. 1965–1972, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Choi, S. C. Huang, R. A. Hawkins et al., “Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models,” Journal of Nuclear Medicine, vol. 40, no. 6, pp. 1045–1055, 1999. View at Google Scholar · View at Scopus
  62. E. J. Hoffman, S. C. Huang, D. Plummer, and M. E. Phelps, “Quantitation in positron emission computed tomography: 6. Effect of nonuniform resolution,” Journal of Computer Assisted Tomography, vol. 6, no. 5, pp. 987–999, 1982. View at Google Scholar · View at Scopus
  63. J. D. Hove, S. S. Gambhir, K. F. Kofoed, J. Freiberg, and H. Kelbæk, “Quantitation of the regional blood flow in the interventricular septum using positron emission tomography and nitrogen-13 ammonia,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 1, pp. 109–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. G. D. Hutchins, J. M. Caraher, and R. R. Raylman, “A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies,” Journal of Nuclear Medicine, vol. 33, no. 6, pp. 1243–1250, 1992. View at Google Scholar · View at Scopus
  65. P. G. Coxson, “Consequences of using a simplified kinetic model for dynamic PET data,” Journal of Nuclear Medicine, vol. 38, no. 4, pp. 660–667, 1997. View at Google Scholar · View at Scopus
  66. R. Klein, J. M. Renaud, M. C. Ziadi et al., “Intra-and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program,” Journal of Nuclear Cardiology, vol. 17, no. 4, pp. 600–616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. S. V. Nesterov, C. Han, M. Mäki et al., “Myocardial perfusion quantification with 15O-labeled water PET: high reproducibility of the new cardiac analysis software (CarimasTM),” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, pp. 1594–1602, 2009. View at Publisher · View at Google Scholar
  68. K. Knešaurek and Z. Zhang, “Repeatability of regional myocardial blood flow calculation in 82Rb PET imaging,” BMC Medical Physics, vol. 9, no. 1, article 2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. G. El Fakhri, A. Kardan, A. Sitek et al., “Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: comparison with 13N-ammonia PET,” Journal of Nuclear Medicine, vol. 50, no. 7, pp. 1062–1071, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. P. J. Slomka, E. Alexanderson, R. Jácome et al., “Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT,” Journal of Nuclear Medicine, vol. 53, pp. 171–181, 2012. View at Publisher · View at Google Scholar
  71. S. Sawada, O. Muzik, R. S. B. Beanlands, E. Wolfe, G. D. Hutchins, and M. Schwaiger, “Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography,” Journal of Nuclear Cardiology, vol. 2, no. 5, pp. 413–422, 1995. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Nagamachi, J. Czernin, A. S. Kim et al., “Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET,” Journal of Nuclear Medicine, vol. 37, no. 10, pp. 1626–1631, 1996. View at Google Scholar · View at Scopus
  73. P. A. Kaufmann, T. Gnecchi-Ruscone, J. T. Yap, O. Rimoldi, and P. G. Camici, “Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET,” Journal of Nuclear Medicine, vol. 40, no. 11, pp. 1848–1856, 1999. View at Google Scholar · View at Scopus
  74. R. Jagathesan, P. A. Kaufmann, S. D. Rosen et al., “Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease,” Journal of Nuclear Medicine, vol. 46, no. 2, pp. 212–219, 2005. View at Google Scholar · View at Scopus
  75. O. Manabe, K. Yoshinaga, C. Katoh, M. Naya, R. A. DeKemp, and N. Tamaki, “Repeatability of rest and hyperemic myocardial blood flow measurements with82Rb dynamic PET,” Journal of Nuclear Medicine, vol. 50, no. 1, pp. 68–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. C. S. Patlak, R. G. Blasberg, and J. D. Fenstermacher, “Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data,” Journal of Cerebral Blood Flow and Metabolism, vol. 3, no. 1, pp. 1–7, 1983. View at Google Scholar · View at Scopus
  77. K. Morita, C. Katoh, K. Yoshinaga et al., “Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 7, pp. 806–812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. P. G. Masci, M. Marinelli, M. Piacenti et al., “Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study,” Circulation: Cardiovascular Imaging, vol. 3, no. 4, pp. 482–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. L. I. Araujo, A. A. Lammertsma, C. G. Rhodes et al., “Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography,” Circulation, vol. 83, no. 3, pp. 875–885, 1991. View at Google Scholar · View at Scopus
  80. E. W. Geltman, G. Henes, M. J. Senneff, B. E. Sobel, and S. R. Bergmann, “Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina angiographically normal coronary arteries,” Journal of the American College of Cardiology, vol. 16, no. 3, pp. 586–595, 1990. View at Google Scholar · View at Scopus
  81. G. Sambuceti, O. Parodi, C. Marcassa et al., “Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography,” American Journal of Cardiology, vol. 72, no. 7, pp. 538–543, 1993. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Y. Chan, R. C. Brunken, J. Czernin et al., “Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men,” Journal of the American College of Cardiology, vol. 20, no. 4, pp. 979–984, 1992. View at Google Scholar · View at Scopus
  83. P. Merlet, B. Mazoyer, L. Hittinger et al., “Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique,” Journal of Nuclear Medicine, vol. 34, no. 11, pp. 1899–1904, 1993. View at Google Scholar · View at Scopus
  84. O. Muzik, R. Beanlands, E. Wolfe, G. D. Hutchins, and M. Schwaiger, “Automated region definition for cardiac nitrogen-13-ammonia PET imaging,” Journal of Nuclear Medicine, vol. 34, no. 2, pp. 336–344, 1993. View at Google Scholar · View at Scopus
  85. J. Czernin, P. Muller, S. Chan et al., “Influence of age and hemodynamics on myocardial blood flow and flow reserve,” Circulation, vol. 88, no. 1, pp. 62–69, 1993. View at Google Scholar · View at Scopus
  86. J. Krivokapich, J. Czernin, and H. R. Schelbert, “Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease,” Journal of the American College of Cardiology, vol. 28, no. 3, pp. 565–572, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Chareonthaitawee, P. A. Kaufmann, O. Rimoldi, and P. G. Camici, “Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans,” Cardiovascular Research, vol. 50, no. 1, pp. 151–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. M. J. Senneff, E. M. Geltman, S. R. Bergmann, and J. Hartman, “Noninvasive delineation of the effects of moderate aging on myocardial perfusion,” Journal of Nuclear Medicine, vol. 32, no. 11, pp. 2037–2042, 1991. View at Google Scholar · View at Scopus
  89. P. G. Camici, R. J. Gropler, T. Jones et al., “The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases,” European Heart Journal, vol. 17, no. 1, pp. 25–34, 1996. View at Google Scholar · View at Scopus
  90. C. S. Duvernoy, C. Meyer, V. Seifert-Klauss et al., “Gender differences in myocardial blood flow dynamics lipid profile and hemodynamic effects,” Journal of the American College of Cardiology, vol. 33, no. 2, pp. 463–470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Sdringola, N. P. Johnson, R. L. Kirkeeide, E. Cid, and K. L. Gould, “Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers,” JACC: Cardiovascular Imaging, vol. 4, no. 4, pp. 402–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. R. O. Cannon, P. G. Camici, and S. E. Epstein, “Pathophysiological dilemma of syndrome X,” Circulation, vol. 85, no. 3, pp. 883–892, 1992. View at Google Scholar · View at Scopus
  93. P. G. Camici, R. Gistri, R. Lorenzoni et al., “Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms,” Circulation, vol. 86, no. 1, pp. 179–186, 1992. View at Google Scholar · View at Scopus
  94. S. D. Rosen, N. G. Uren, J. C. Kaski, D. Tousoulis, G. J. Davies, and P. G. Camici, “Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X,” Circulation, vol. 90, no. 1, pp. 50–60, 1994. View at Google Scholar · View at Scopus
  95. M. Bøttcher, H. E. Bøtker, H. Sonne, T. T. Nielsen, and J. Czernin, “Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X,” Circulation, vol. 99, no. 14, pp. 1795–1801, 1999. View at Google Scholar · View at Scopus
  96. S. Graf, A. Khorsand, M. Gwechenberger et al., “Myocardial perfusion in patients with typical chest pain and normal angiogram,” European Journal of Clinical Investigation, vol. 36, no. 5, pp. 326–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Graf, A. Khorsand, M. Gwechenberger et al., “Typical chest pain and normal coronary angiogram: cardiac risk factor analysis versus PET for detection of microvascular disease,” Journal of Nuclear Medicine, vol. 48, no. 2, pp. 175–181, 2007. View at Google Scholar · View at Scopus
  98. R. Gistri, A. G. Ebert, C. Palombo, C. Marabotti, L. Choudhury, and P. G. Camici, “Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension,” Cardiovascular Drugs and Therapy, vol. 8, no. 1, pp. 169–171, 1994. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Higuchi, C. Abletshauser, S. G. Nekolla, M. Schwaiger, and F. M. Bengel, “Effect of the angiotensin receptor blocker valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease,” Microcirculation, vol. 14, no. 8, pp. 805–812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Naya, T. Tsukamoto, K. Morita et al., “Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients,” Journal of the American College of Cardiology, vol. 50, no. 12, pp. 1144–1149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Choudhury, S. D. Rosen, D. Patel, P. Nihoyannopoulos, and P. G. Camici, “Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography,” European Heart Journal, vol. 18, no. 1, pp. 108–116, 1997. View at Google Scholar · View at Scopus
  102. M. H. Olsen, K. Wachtell, C. Meyer et al., “Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy,” Journal of Human Hypertension, vol. 18, no. 6, pp. 445–452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. H. Laine, O. T. Raitakari, H. Niinikoski et al., “Early impairment of coronary flow reserve in young men with borderline hypertension,” Journal of the American College of Cardiology, vol. 32, no. 1, pp. 147–153, 1998. View at Publisher · View at Google Scholar · View at Scopus
  104. O. P. Pitkänen, P. Nuutila, O. T. Raitakari et al., “Coronary flow reserve is reduced in young men with IDDM,” Diabetes, vol. 47, no. 2, pp. 248–254, 1998. View at Google Scholar · View at Scopus
  105. I. Yokoyama, S. I. Momomura, T. Ohtake et al., “Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus,” Journal of the American College of Cardiology, vol. 30, no. 6, pp. 1472–1477, 1997. View at Publisher · View at Google Scholar · View at Scopus
  106. M. F. Di Carli, D. Bianco-Batlles, M. E. Landa et al., “Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus,” Circulation, vol. 100, no. 8, pp. 813–819, 1999. View at Google Scholar · View at Scopus
  107. M. Momose, C. Abletshauser, J. Neverve et al., “Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus,” European Journal of Nuclear Medicine, vol. 29, no. 12, pp. 1675–1679, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. M. F. Di Carli, L. Afonso, R. Campisi et al., “Coronary vascular dysfunction in premenopausal women with diabetes mellitus,” American Heart Journal, vol. 144, no. 4, pp. 711–718, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. M. F. Di Carli, J. Janisse, G. Grunberger, and J. Ager, “Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes,” Journal of the American College of Cardiology, vol. 41, no. 8, pp. 1387–1393, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. M. J. Quiñones, M. Hernandez-Pampaloni, H. Schelbert et al., “Coronary vasomotor abnormalities in insulin-resistant individuals,” Annals of Internal Medicine, vol. 140, no. 9, pp. 700–708, 2004. View at Google Scholar · View at Scopus
  111. J. O. Prior, M. J. Quiñones, M. Hernandez-Pampaloni et al., “Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus,” Circulation, vol. 111, no. 18, pp. 2291–2298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. F. M. Bengel, C. Abletshausert, J. Neverve et al., “Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus—a randomized study using positron emission tomography,” Diabetic Medicine, vol. 22, no. 2, pp. 158–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. R. Lautamäki, K. E. J. Airaksinen, M. Seppänen et al., “Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease,” Diabetes, vol. 55, no. 2, pp. 511–516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. T. H. Schindler, A. D. Facta, J. O. Prior et al., “Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes,” Heart, vol. 93, no. 3, pp. 345–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. T. H. Schindler, A. D. Facta, J. O. Prior et al., “Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 2, pp. 219–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. T. H. Schindler, J. Cadenas, A. D. Facta et al., “Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus,” European Heart Journal, vol. 30, no. 24, pp. 3064–3073, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. O. P. Pitkänen, O. T. Raitakari, H. Niinikoski et al., “Coronary flow reserve is impaired in young men with familial hypercholesterolemia,” Journal of the American College of Cardiology, vol. 28, pp. 1705–1711, 1996. View at Publisher · View at Google Scholar
  118. O. P. Pitkänen, P. Nuutila, O. T. Raitakari et al., “Coronary flow reserve in young men with familial combined hyperlipidemia,” Circulation, vol. 99, no. 13, pp. 1678–1684, 1999. View at Google Scholar · View at Scopus
  119. I. Yokoyama, T. Ohtake, S. I. Momomura, J. Nishikawa, Y. Sasaki, and M. Omata, “Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis,” Circulation, vol. 94, no. 12, pp. 3232–3238, 1996. View at Google Scholar · View at Scopus
  120. F. Dayanikli, D. Grambow, O. Muzik, L. Mosca, M. Rubenfire, and M. Schwaiger, “Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography,” Circulation, vol. 90, no. 2, pp. 808–817, 1994. View at Google Scholar · View at Scopus
  121. P. A. Kaufmann, T. Gnecchi-Ruscone, K. P. Schäfers, T. F. Lüscher, and P. G. Camici, “Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia,” Journal of the American College of Cardiology, vol. 36, no. 1, pp. 103–109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  122. J. Czernin, R. J. Barnard, K. T. Sun et al., “Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve,” Circulation, vol. 92, no. 2, pp. 197–204, 1995. View at Google Scholar · View at Scopus
  123. T. Janatuinen, R. Laaksonen, R. Vesalainen et al., “Effect of lipid-lowering therapy with pravastatin on myocardial blood flow in young mildly hypercholesterolemic adults,” Journal of Cardiovascular Pharmacology, vol. 38, no. 4, pp. 561–568, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. I. Yokoyama, K. Yonekura, Y. Inoue, K. Ohtomo, and R. Nagai, “Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance,” Journal of Nuclear Cardiology, vol. 8, no. 4, pp. 445–451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Guethlin, A. M. Kasel, K. Coppenrath, S. Ziegler, W. Delius, and M. Schwaiger, “Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin,” Circulation, vol. 99, no. 4, pp. 475–481, 1999. View at Google Scholar · View at Scopus
  126. G. S. Huggins, R. C. Pasternak, N. M. Alpert, A. J. Fischman, and H. Gewirtz, “Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse,” Circulation, vol. 98, no. 13, pp. 1291–1296, 1998. View at Google Scholar · View at Scopus
  127. P. Wielepp, D. Baller, U. Gleichmann, E. Pulawski, D. Horstkotte, and W. Burchert, “Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 12, pp. 1371–1377, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. I. Yokoyama, S. I. Momomura, T. Ohtake et al., “Improvement of impaired myocardial vasodilatation due to diffuse coronary atherosclerosis in hypercholesterolemics after lipid-lowering therapy,” Circulation, vol. 100, no. 2, pp. 117–122, 1999. View at Google Scholar · View at Scopus
  129. D. Baller, G. Notohamiprodjo, U. Gleichmann, J. Holzinger, R. Weise, and J. Lehmann, “Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis,” Circulation, vol. 99, no. 22, pp. 2871–2875, 1999. View at Google Scholar · View at Scopus
  130. R. Campisi, J. Czernin, H. Schöder et al., “Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity,” Circulation, vol. 98, no. 2, pp. 119–125, 1998. View at Google Scholar · View at Scopus
  131. P. A. Kaufmann, T. Gnecchi-Ruscone, M. di Terlizzi, K. P. Schäfers, T. F. Lüscher, and P. G. Camici, “Coronary heart desease in smokers: vitamin C restores coronary microcirculatory function,” Circulation, vol. 102, no. 11, pp. 1233–1238, 2000. View at Google Scholar · View at Scopus
  132. K. Morita, T. Tsukamoto, M. Naya et al., “Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers,” Journal of Nuclear Medicine, vol. 47, no. 12, pp. 1914–1920, 2006. View at Google Scholar · View at Scopus
  133. T. H. Schindler, E. U. Nitzsche, M. Olschewski et al., “Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors,” Circulation, vol. 110, no. 9, pp. 1069–1075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  134. T. H. Schindler, J. Cardenas, J. O. Prior et al., “Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function,” Journal of the American College of Cardiology, vol. 47, no. 6, pp. 1188–1195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Campisi, L. Nathan, M. H. Pampaloni et al., “Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration,” Circulation, vol. 105, no. 4, pp. 425–430, 2002. View at Publisher · View at Google Scholar · View at Scopus
  136. N. G. Uren, J. A. Melin, B. De Bruyne, W. Wijns, T. Baudhuin, and P. G. Camici, “Relation between myocardial blood flow and the severity of coronary- artery stenosis,” The New England Journal of Medicine, vol. 330, no. 25, pp. 1782–1788, 1994. View at Publisher · View at Google Scholar · View at Scopus
  137. M. Di Carli, J. Czernin, C. K. Hoh et al., “Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease,” Circulation, vol. 91, no. 7, pp. 1944–1951, 1995. View at Google Scholar · View at Scopus
  138. R. A. Goldstein, R. L. Kirkeeide, and L. L. Demer, “Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man,” Journal of Clinical Investigation, vol. 79, no. 5, pp. 1473–1478, 1987. View at Google Scholar · View at Scopus
  139. R. S. Beanlands, O. Muzik, P. Melon et al., “Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity,” Journal of the American College of Cardiology, vol. 26, no. 6, pp. 1465–1475, 1995. View at Publisher · View at Google Scholar · View at Scopus
  140. C. Anagnostopoulos, A. Almonacid, G. El Fakhri et al., “Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 9, pp. 1593–1601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  141. R. Campisi, J. Czernin, H. L. Karpman, and H. R. Schelbert, “Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery,” American Journal of Cardiology, vol. 80, no. 1, pp. 27–31, 1997. View at Publisher · View at Google Scholar · View at Scopus
  142. I. Kosa, R. Blasini, J. Schneider-Eicke et al., “Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography,” Journal of the American College of Cardiology, vol. 34, no. 4, pp. 1036–1041, 1999. View at Publisher · View at Google Scholar · View at Scopus
  143. K. Yoshinaga, C. Katoh, O. Manabe et al., “Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET,” Circulation Journal, vol. 75, pp. 2628–2634, 2011. View at Publisher · View at Google Scholar
  144. N. P. Johnson and K. L. Gould, “Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve,” JACC: Cardiovascular Imaging, vol. 4, pp. 990–998, 2011. View at Publisher · View at Google Scholar
  145. J. Radvan, T. H. Marwick, M. J. Williams, and P. G. Camici, “Evaluation of the extent and timing of the coronary hyperemic response to dipyridamole: a study with transesophageal echocardiography and positron emission tomography with oxygen 15 water,” Journal of the American Society of Echocardiography, vol. 8, no. 6, pp. 864–873, 1995. View at Google Scholar · View at Scopus
  146. L. L. Demer, K. L. Gould, R. A. Goldstein, and R. L. Kirkeeide, “Noninvasive assessment of coronary collaterals in man by PET perfusion imaging,” Journal of Nuclear Medicine, vol. 31, no. 3, pp. 259–270, 1990. View at Google Scholar · View at Scopus
  147. E. O. McFalls, L. I. Araujo, A. Lammertsma et al., “Vasodilator reserve in collateral-dependent myocardium as measured by positron emission tomography,” European Heart Journal, vol. 14, no. 3, pp. 336–343, 1993. View at Google Scholar · View at Scopus
  148. J. L. J. Vanoverschelde, W. Wijns, C. Depre et al., “Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium,” Circulation, vol. 87, no. 5, pp. 1513–1523, 1993. View at Google Scholar · View at Scopus
  149. M. F. Di Carli and R. Hachamovitch, “New technology for noninvasive evaluation of coronary artery disease,” Circulation, vol. 115, no. 11, pp. 1464–1480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. T. M. Bateman, G. V. Heller, A. I. McGhie et al., “Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT,” Journal of Nuclear Cardiology, vol. 13, no. 1, pp. 24–33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  151. K. L. Gould, R. A. Goldstein, and N. A. Mullani, “Economic analysis of clinical positron emission tomography of the heart with rubidium-82,” Journal of Nuclear Medicine, vol. 30, no. 5, pp. 707–717, 1989. View at Google Scholar · View at Scopus
  152. R. E. Patterson, R. L. Eisner, and S. F. Horowitz, “Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease,” Circulation, vol. 91, no. 1, pp. 54–65, 1995. View at Google Scholar · View at Scopus
  153. M. E. Merhige, W. J. Breen, V. Shelton, T. Houston, B. J. D'Arcy, and A. F. Perna, “Impact of myocardial perfusion imaging with PET and 82Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management,” Journal of Nuclear Medicine, vol. 48, no. 7, pp. 1069–1076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. A. J. Einstein, K. W. Moser, R. C. Thompson, M. D. Cerqueira, and M. J. Henzlova, “Radiation dose to patients from cardiac diagnostic imaging,” Circulation, vol. 116, no. 11, pp. 1290–1305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Achenbach, K. Anders, and W. A. Kalender, “Dual-source cardiac computed tomography: image quality and dose considerations,” European Radiology, vol. 18, no. 6, pp. 1188–1198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  156. R. C. Thompson and S. J. Cullom, “Issues regarding radiation dosage of cardiac nuclear and radiography procedures,” Journal of Nuclear Cardiology, vol. 13, no. 1, pp. 19–23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  157. R. C. Hendel, D. S. Berman, M. F. Di Carli et al., “ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography,” Journal of the American College of Cardiology, vol. 53, no. 23, pp. 2201–2229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. G. A. Beller, “Underestimation of coronary artery disease with SPECT perfusion imaging,” Journal of Nuclear Cardiology, vol. 15, no. 2, pp. 151–153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. D. S. Berman, X. Kang, P. J. Slomka et al., “Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease,” Journal of Nuclear Cardiology, vol. 14, no. 4, pp. 521–528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  160. K. Yoshinaga, C. Katoh, K. Noriyasu et al., “Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET,” Journal of Nuclear Cardiology, vol. 10, no. 3, pp. 275–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  161. R. Parkash, R. A. deKemp, T. D. Ruddy et al., “Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease,” Journal of Nuclear Cardiology, vol. 11, no. 4, pp. 440–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  162. R. Seth, R. A. deKemp, B. Hart et al., “Quantification of absolute perfusion reserve using 82Rb positron emission tomography defines greater extent of disease in three vessel coronary atherosclerosis,” Journal of the American College of Cardiology, vol. 37, article 387A, 2001. View at Google Scholar
  163. M. M. Hajjiri, M. B. Leavitt, H. Zheng, A. E. Spooner, A. J. Fischman, and H. Gewirtz, “Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location,” JACC: Cardiovascular Imaging, vol. 2, no. 6, pp. 751–758, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. T. A. Pearson, “New tools for coronary risk assessment: what are their advantages and limitations?” Circulation, vol. 105, no. 7, pp. 886–892, 2002. View at Publisher · View at Google Scholar · View at Scopus
  165. K. L. Gould, “Does coronary flow trump coronary anatomy?” JACC: Cardiovascular Imaging, vol. 2, no. 8, pp. 1009–1023, 2009. View at Publisher · View at Google Scholar · View at Scopus
  166. T. H. Marwick, K. Shan, S. Patel, R. T. Go, and M. S. Lauer, “Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease,” American Journal of Cardiology, vol. 80, no. 7, pp. 865–870, 1997. View at Publisher · View at Google Scholar · View at Scopus
  167. W. J. MacIntyre, R. T. Go, J. L. King et al., “Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging,” Journal of Nuclear Medicine, vol. 34, no. 3, pp. 400–404, 1993. View at Google Scholar · View at Scopus
  168. K. Yoshinaga, B. J. W. Chow, K. Williams et al., “What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography?” Journal of the American College of Cardiology, vol. 48, no. 5, pp. 1029–1039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  169. S. Dorbala, R. Hachamovitch, Z. Curillova et al., “Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF,” JACC: Cardiovascular Imaging, vol. 2, no. 7, pp. 846–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. T. H. Schindler, E. U. Nitzsche, H. R. Schelbert et al., “Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events,” Journal of the American College of Cardiology, vol. 45, no. 9, pp. 1505–1512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. R. A. Tio, A. Dabeshlim, H. M. J. Siebelink et al., “Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease,” Journal of Nuclear Medicine, vol. 50, no. 2, pp. 214–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. B. A. Herzog, L. Husmann, I. Valenta et al., “Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography. Added value of coronary flow reserve,” Journal of the American College of Cardiology, vol. 54, no. 2, pp. 150–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  173. K. Fukushima, M. S. Javadi, T. Higuchi et al., “Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging,” Journal of Nuclear Medicine, vol. 52, no. 5, pp. 726–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. M. C. Ziadi, R. A. Dekemp, K. A. Williams et al., “Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia,” Journal of the American College of Cardiology, vol. 58, no. 7, pp. 740–748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  175. V. L. Murthy, M. Naya, C. R. Foster et al., “Improved cardiac risk assessment with noninvasive measures of coronary flow reserve,” Circulation, vol. 124, pp. 2215–2224, 2011. View at Publisher · View at Google Scholar
  176. P. G. Camici and F. Crea, “Coronary microvascular dysfunction,” New England Journal of Medicine, vol. 356, no. 8, pp. 830–840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  177. Y. W. Wu, Y. H. Chen, S. S. Wang et al., “PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients,” Journal of Nuclear Medicine, vol. 51, no. 6, pp. 906–912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. B. J. Maron, S. E. Epstein, and W. C. Roberts, “Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries,” American Journal of Cardiology, vol. 43, no. 6, pp. 1086–1102, 1979. View at Google Scholar · View at Scopus
  179. A. Pasternac, J. Noble, and Y. Streulens, “Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries,” Circulation, vol. 65, no. 4, pp. 778–789, 1982. View at Google Scholar · View at Scopus
  180. P. Camici, G. Chiriatti, R. Lorenzoni et al., “Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography,” Journal of the American College of Cardiology, vol. 17, no. 4, pp. 879–886, 1991. View at Google Scholar · View at Scopus
  181. L. Choudhury, P. Elliott, O. Rimoldi et al., “Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment,” Basic Research in Cardiology, vol. 94, no. 1, pp. 49–59, 1999. View at Publisher · View at Google Scholar · View at Scopus
  182. B. J. Maron, J. K. Wolfson, S. E. Epstein, and W. C. Roberts, “Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 8, no. 3, pp. 545–557, 1986. View at Google Scholar · View at Scopus
  183. P. Knaapen, T. Germans, P. G. Camici et al., “Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy,” American Journal of Physiology, vol. 294, no. 2, pp. H986–H993, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. B. Sotgia, R. Sciagrà, I. Olivotto et al., “Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy,” Journal of Nuclear Medicine, vol. 49, no. 7, pp. 1090–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  185. R. Sciagrà, B. Sotgia, I. Olivotto et al., “Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy,” Journal of Nuclear Cardiology, vol. 16, no. 1, pp. 92–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. I. Olivotto, F. Girolami, R. Sciagrà et al., “Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations,” Journal of the American College of Cardiology, vol. 58, pp. 839–848, 2011. View at Publisher · View at Google Scholar
  187. F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P. G. Camici, “Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy,” The New England Journal of Medicine, vol. 349, no. 11, pp. 1027–1035, 2003. View at Publisher · View at Google Scholar · View at Scopus
  188. I. Olivotto, F. Cecchi, R. Gistri et al., “Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy,” Journal of the American College of Cardiology, vol. 47, no. 5, pp. 1043–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  189. P. M. Elliott, H. Kindler, J. S. Shah et al., “Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with α galactosidase A,” Heart, vol. 92, no. 3, pp. 357–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  190. B. Tomberli, A. Fornaro, R. Sciagrà et al., “Coronary microvascular dysfunction as an early feature of cardiac involvement in male and female patients with Fabry disease,” European Journal of Heart Failure, vol. 11, supplement 1, p. S6, 2012. View at Google Scholar
  191. M. B. Weiss, K. Ellis, R. R. Sciacca, L. L. Johnson, D. H. Schmidt, and P. J. Cannon, “Myocardial blood flow in congestive and hypertrophic cardiomyopathy. Relationship to peak wall stress and mean velocity of circumferential fiber shortening,” Circulation, vol. 54, no. 3, pp. 484–494, 1976. View at Google Scholar · View at Scopus
  192. D. Neglia, O. Parodi, M. Gallopin et al., “Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure: a quantitative assessment by positron emission tomography,” Circulation, vol. 92, no. 4, pp. 796–804, 1995. View at Google Scholar · View at Scopus
  193. D. Opherk, F. Schwarz, and G. Mall, “Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients,” American Journal of Cardiology, vol. 51, no. 10, pp. 1657–1662, 1983. View at Google Scholar · View at Scopus
  194. M. Canetti, M. W. Akhter, A. Lerman et al., “Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy,” American Journal of Cardiology, vol. 92, no. 10, pp. 1246–1249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  195. K. Q. Stolen, J. Kemppainen, K. K. Kalliokoski et al., “Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy,” American Journal of Cardiology, vol. 93, no. 1, pp. 64–68, 2004. View at Publisher · View at Google Scholar · View at Scopus
  196. D. Neglia, C. Michelassi, M. Giovanna Trivieri et al., “Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction,” Circulation, vol. 105, no. 2, pp. 186–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  197. H. Gewirtz, “Cardiac PET: a versatile, quantitative measurement tool for heart failure management,” JACC: Cardiovascular Imaging, vol. 4, no. 3, pp. 292–302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  198. P. Shah, B. G. Choi, and R. Mazhari, “Positron emission tomography for the evaluation and treatment of cardiomyopathy,” Annals of the New York Academy of Sciences, vol. 1228, no. 1, pp. 137–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  199. D. Neglia, R. De Maria, S. Masi et al., “Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy,” Heart, vol. 93, no. 7, pp. 808–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  200. A. Gimelli, J. Schneider-Eicke, D. Neglia et al., “Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy,” Journal of the American College of Cardiology, vol. 31, no. 2, pp. 366–373, 1998. View at Publisher · View at Google Scholar · View at Scopus
  201. M. Namdar, T. F. Hany, P. Koepfli et al., “Integrated PET/CT for the assessment of coronary artery disease: a feasibility study,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 930–935, 2005. View at Google Scholar · View at Scopus
  202. M. F. Di Carli, S. Dorbala, Z. Curillova et al., “Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging,” Journal of Nuclear Cardiology, vol. 14, no. 6, pp. 799–809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  203. M. P. Schenker, S. Dorbala, E. C. T. Hong et al., “Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study,” Circulation, vol. 117, no. 13, pp. 1693–1700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  204. C. A. Santana, R. D. Folks, E. V. Garcia et al., “Quantitative 82Rb PET/CT: development and validation of myocardial perfusion database,” Journal of Nuclear Medicine, vol. 48, no. 7, pp. 1122–1128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  205. U. K. Sampson, S. Dorbala, A. Limaye, R. Kwong, and M. F. Di Carli, “Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease,” Journal of the American College of Cardiology, vol. 49, no. 10, pp. 1052–1058, 2007. View at Publisher · View at Google Scholar · View at Scopus
  206. S. Kajander, E. Joutsiniemi, M. Saraste et al., “Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease,” Circulation, vol. 122, no. 6, pp. 603–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  207. M. Naya, V. L. Murthy, R. Blankstein et al., “Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion,” Journal of the American College of Cardiology, vol. 58, pp. 1807–1816, 2011. View at Publisher · View at Google Scholar
  208. N. Burkhard, B. A. Herzog, L. Husmann et al., “Coronary calcium score scans for attenuation correction of quantitative PET/CT 13N-ammonia myocardial perfusion imaging,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 3, pp. 517–521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  209. J. Knuuti, “Are Coronary plaque characteristics on computed tomography angiography associated with myocardial perfusion?” Journal of the American College of Cardiology, vol. 58, pp. 1817–1818, 2011. View at Publisher · View at Google Scholar
  210. R. Liga, C. Marini, M. Coceani et al., “Structural abnormalities of the coronary arterial wall in addition to luminal narrowing affect myocardial blood flow reserve,” Journal of Nuclear Medicine, vol. 52, pp. 1704–1712, 2011. View at Publisher · View at Google Scholar
  211. M. Naya and M. F. Di Carli, “Myocardial perfusion PET/CT to evaluate known and suspected coronary artery disease,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 54, no. 2, pp. 145–156, 2010. View at Google Scholar · View at Scopus
  212. M. Javadi, M. Mahesh, G. McBride et al., “Lowering radiation dose for integrated assessment of coronary morphology and physiology: first experience with step-and-shoot CT angiography in a rubidium 82 PET-CT protocol,” Journal of Nuclear Cardiology, vol. 15, no. 6, pp. 783–790, 2008. View at Publisher · View at Google Scholar · View at Scopus
  213. S. Kajander, H. Ukkonen, H. Sipilä, M. Teräs, and J. Knuuti, “Low radiation dose imaging of myocardial perfusion and coronary angiography with a hybrid PET/CT scanner,” Clinical Physiology and Functional Imaging, vol. 29, no. 1, pp. 81–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  214. D. C. Lee and N. P. Johnson, “Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging,” JACC: Cardiovascular Imaging, vol. 2, no. 6, pp. 761–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  215. T. Dill, “Contraindications to magnetic resonance imaging,” Heart, vol. 94, no. 7, pp. 943–948, 2008. View at Publisher · View at Google Scholar · View at Scopus
  216. Y. Nakauchi, Y. Iwanaga, S. Ikuta et al., “Quantitative myocardial perfusion analysis using multi-row detector CT in acute myocardial infarction,” Heart, vol. 98, pp. 566–572, 2012. View at Publisher · View at Google Scholar
  217. G. A. Beller, “Recent advances and future trends in multimodality cardiac imaging,” Heart Lung and Circulation, vol. 19, no. 3, pp. 193–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  218. M. Yu, S. G. Nekolla, M. Schwaiger, and S. P. Robinson, “The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease,” Seminars in Nuclear Medicine, vol. 41, no. 4, pp. 305–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  219. D. S. Berman, G. Germano, and P. J. Slomka, “Improvement in PET myocardial perfusion image quality and quantification with flurpiridaz F 18,” Journal of Nuclear Cardiology, vol. 19, pp. S38–S45, 2012. View at Publisher · View at Google Scholar
  220. S. G. Nekolla, S. Reder, A. Saraste et al., “Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model,” Circulation, vol. 119, no. 17, pp. 2333–2342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  221. H. M. Sherif, S. G. Nekolla, A. Saraste et al., “Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model,” Journal of Nuclear Medicine, vol. 52, no. 4, pp. 617–624, 2011. View at Publisher · View at Google Scholar · View at Scopus
  222. J. Maddahi, S. Huang, D. Truong et al., “Preliminary results of absolute quantification of rest and stress myocardial blood flow with flurpiridaz F-18 PET in normal and coronary artery disease patients in a single-center study,” Journal of Nuclear Cardiology, vol. 17, article 743, 2010. View at Google Scholar
  223. P. C. Vermeeren, “Nuclear cardiology in Europe: nuclear medicine physicians tend to build walls around their skills and thereby limit the growth of the field,” Journal of Nuclear Cardiology, vol. 6, no. 2, pp. 241–244, 1999. View at Publisher · View at Google Scholar · View at Scopus
  224. C. Marcassa, A. Bischof Delaloye, A. Cuocolo et al., “The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 12, pp. 1508–1512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  225. R. Hachamovitch, J. R. Johnson, M. A. Hlatky et al., “The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes,” Journal of Nuclear Cardiology, vol. 16, no. 6, pp. 935–948, 2009. View at Publisher · View at Google Scholar · View at Scopus
  226. R. Hachamovitch, B. Nutter, M. A. Hlatky, SPARC Investigators et al., “Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease),” Journal of the American College of Cardiology, vol. 59, pp. 462–474, 2012. View at Publisher · View at Google Scholar